• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗慢性、中度至重度非恶性疼痛的硫酸吗啡缓释胶囊(奥施康定)。

KADIAN (morphine sulfate extended-release) capsules for treatment of chronic, moderate-to-severe, nonmalignant pain.

作者信息

Ross E L, Hahn K

机构信息

Pain Management Center, Brigham and Women's Hospital, Chestnut Hill, MA 02467, USA.

出版信息

Int J Clin Pract. 2008 Mar;62(3):471-9. doi: 10.1111/j.1742-1241.2007.01688.x.

DOI:10.1111/j.1742-1241.2007.01688.x
PMID:18261077
Abstract

Chronic pain, one of the most common reasons for which patients seek medical attention, is defined as pain that persists beyond the normal healing time, usually about 3 months. Chronic pain can be malignant or nonmalignant in origin, or can appear in the absence of identifiable pathology. Pharmacological treatment options include non-opioid and opioid analgesics, as well as adjuvant medications. Opioids, the most potent analgesics, are typically reserved for the treatment of chronic, moderate-to-severe pain that has not responded to non-opioid therapy. Morphine remains the gold standard among commonly used opioids. Long-acting opioids are formulated to offer continuous delivery of analgesia around the clock. These agents are formulated to maintain therapeutic blood levels of morphine, with minimal fluctuations. KADIAN Capsules, which contain polymer-coated extended-release morphine sulfate pellets, is one such formulation available for the treatment of moderate-to-severe pain for which an analgesic is indicated for more than a few days. This article reviews KADIAN and identifies unique features from early pharmacokinetic and pharmacodynamic studies, recent data on pharmacokinetic interactions with alcohol and results from recent trials in treating nonmalignant pain.

摘要

慢性疼痛是患者寻求医疗关注的最常见原因之一,被定义为持续超过正常愈合时间(通常约3个月)的疼痛。慢性疼痛的起源可以是恶性或非恶性的,也可能在没有可识别的病理情况下出现。药物治疗选择包括非阿片类和阿片类镇痛药以及辅助药物。阿片类药物是最有效的镇痛药,通常用于治疗对非阿片类治疗无反应的慢性中度至重度疼痛。吗啡仍然是常用阿片类药物中的金标准。长效阿片类药物的设计目的是提供全天候的持续镇痛。这些制剂旨在维持吗啡的治疗血药浓度,波动最小。KADIAN胶囊含有聚合物包衣的缓释硫酸吗啡微丸,是一种可用于治疗中度至重度疼痛且需要使用镇痛药数天以上的制剂。本文回顾了KADIAN,并从早期药代动力学和药效学研究、近期与酒精的药代动力学相互作用数据以及近期治疗非恶性疼痛的试验结果中确定了其独特特征。

相似文献

1
KADIAN (morphine sulfate extended-release) capsules for treatment of chronic, moderate-to-severe, nonmalignant pain.用于治疗慢性、中度至重度非恶性疼痛的硫酸吗啡缓释胶囊(奥施康定)。
Int J Clin Pract. 2008 Mar;62(3):471-9. doi: 10.1111/j.1742-1241.2007.01688.x.
2
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).阿片类药物与老年人慢性重度疼痛的管理:一个国际专家小组的共识声明,重点关注世界卫生组织第三阶梯临床最常用的六种阿片类药物(丁丙诺啡、芬太尼、氢吗啡酮、美沙酮、吗啡、羟考酮)。
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
3
Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain.比较聚合物包衣缓释硫酸吗啡与盐酸羟考酮控释片治疗中重度非恶性疼痛的随机试验。
Curr Med Res Opin. 2006 Aug;22(8):1503-14. doi: 10.1185/030079906X115603.
4
Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules.用聚合物包衣的硫酸吗啡缓释胶囊治疗慢性中重度非恶性疼痛。
Curr Med Res Opin. 2006 Mar;22(3):539-50. doi: 10.1185/030079906X89784.
5
Effect of concomitant ingestion of alcohol on the in vivo pharmacokinetics of KADIAN (morphine sulfate extended-release) capsules.同时摄入酒精对硫酸吗啡缓释胶囊(KADIAN)体内药代动力学的影响。
J Pain. 2008 Apr;9(4):330-6. doi: 10.1016/j.jpain.2007.11.009. Epub 2008 Jan 16.
6
Long-term safety and efficacy of morphine sulfate and naltrexone hydrochloride extended release capsules, a novel formulation containing morphine and sequestered naltrexone, in patients with chronic, moderate to severe pain.硫酸吗啡和盐酸纳曲酮缓释胶囊(一种含有吗啡和隔离纳曲酮的新型制剂)治疗慢性中重度疼痛患者的长期安全性和疗效。
J Pain Symptom Manage. 2010 Nov;40(5):734-46. doi: 10.1016/j.jpainsymman.2010.05.004.
7
Morphine sulfate and naltrexone hydrochloride extended release capsules in patients with chronic osteoarthritis pain.硫酸吗啡和盐酸纳曲酮缓释胶囊治疗慢性骨关节炎疼痛。
Postgrad Med. 2010 Jul;122(4):112-28. doi: 10.3810/pgm.2010.07.2179.
8
A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.一项随机、双盲、安慰剂对照、交叉试点研究,旨在评估长期服用阿片类药物及随后戒断对接受缓释吗啡治疗的慢性非癌性疼痛患者的影响。
Pain Med. 2005 Mar-Apr;6(2):113-21. doi: 10.1111/j.1526-4637.2005.05020.x.
9
Morphine sulfate extended-release capsules for the treatment of chronic, moderate-to-severe pain.硫酸吗啡缓释胶囊用于治疗慢性中重度疼痛。
Expert Opin Pharmacother. 2008 Jun;9(9):1585-94. doi: 10.1517/14656566.9.9.1585.
10
A study of AVINZA (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions--the ACCPT Study.一项在实际治疗条件下开展的关于AVINZA(硫酸吗啡缓释胶囊)用于慢性中重度非癌性疼痛的研究——ACCPT研究。
Pain Pract. 2006 Dec;6(4):254-64. doi: 10.1111/j.1533-2500.2006.00094.x.

引用本文的文献

1
PolyMorphine provides extended analgesic-like effects in mice with spared nerve injury.聚吗啡在神经损伤保留模型的小鼠中提供了延长的镇痛样效果。
Mol Pain. 2017 Jan-Dec;13:1744806917743479. doi: 10.1177/1744806917743479.
2
PolyMorphine: an innovative biodegradable polymer drug for extended pain relief.聚吗啡:一种用于延长止痛效果的创新型可生物降解聚合物药物。
J Control Release. 2012 Sep 28;162(3):538-44. doi: 10.1016/j.jconrel.2012.07.033. Epub 2012 Aug 3.